Carvedilol Phosphate Capsule, Extended Release
Product Images NDC 51407-050

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Carvedilol Phosphate (NDC 51407-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Carvedilol 1)

Chemical structure of Carvedilol Phosphate showing its molecular framework including the hydroxypropyl and methoxyphenyl groups, with phosphate and water of hydration indicated.*

FDA Label Image

Figure-1 (Carvedilol Figure1)

A line graph showing percent mortality over months up to 21, comparing two groups: one labeled Carvedilol and the other Placebo. The Carvedilol group shows a lower mortality percentage compared to Placebo, with a p-value of 0.0014 indicated on the graph.*

FDA Label Image

Figure-2 (Carvedilol Spl Figure 2)

A forest plot illustrating hazard ratios for various subgroups including men, women, age groups, race, diabetic status, ischemic condition, heart rate, systolic blood pressure levels, and spironolactone use, with confidence intervals plotted around each hazard ratio value. The chart visually compares outcomes across these patient characteristics with a reference line at a hazard ratio of 1.0.*

FDA Label Image

Figure-3 (Carvedilol Figure3)

A line chart comparing percent mortality over 24 months between Carvedilol Phosphate extended-release and placebo groups. The x-axis represents time in months, and the y-axis shows mortality percentage, with Carvedilol group showing lower mortality rates compared to placebo.*

FDA Label Image

Figure-4 (Carvedilol Spl Figure 4)

A hazard ratio forest plot chart divided into two panels presenting risk comparisons across various patient subgroups. The x-axis represents hazard ratios ranging from 0.4 to 1.3. Subgroups include age, gender, timing of randomization post-myocardial infarction (MI), prior beta-blocker use, Killip class, thrombolytic therapy, PTCA for MI, heart failure history, diuretic use during MI, angina presence, hypertension status, diabetes status, heart rate, and systolic blood pressure. The chart visualizes risk effect estimates with confidence intervals for these variables.*

FDA Label Image

Figure (Carvedilol 2)

Two line graphs showing the change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) over 24 hours after a morning dose of carvedilol phosphate extended-release capsules at 20 mg, 40 mg, and 80 mg dosages. Each graph plots time in hours on the x-axis against blood pressure change in mmHg on the y-axis, displaying distinct curves for each strength smoothed using locally weighted regression methodology.*

FDA Label Image

51407-050-30ol.jpg (51407 050 30ol)

Label for Carvedilol Phosphate extended-release capsules, 10 mg strength, containing 30 capsules per bottle. The label shows the product name prominently in blue and black text, with 'Once a Day Dosing' noted in a blue oval. The labeler is Golden State Medical Supply, Inc. Additional labeling includes a barcode, storage information at 20° to 25°C, and a notation that it is Rx only.*

FDA Label Image

51407-051-30ol.jpg (51407 051 30ol)

Label for Carvedilol Phosphate extended-release capsules, 20 mg strength, containing 30 capsules. The label includes dosage form and strength, NDC number 51407-051-30, a barcode, and the manufacturer information, Golden State Medical Supply, Inc. Instructions to see the package insert for dosing and storage at 20° to 25°C are present, along with a note that the product is for Rx only.*

FDA Label Image

51407-052-30ol.jpg (51407 052 30ol)

Label for Carvedilol Phosphate extended-release capsules, 40 mg strength, in a package containing 30 capsules. The label shows the product name, dosage form, strength, and a note for once a day dosing. The labeler is Golden State Medical Supply, Inc., and includes storage conditions and a barcode.*

FDA Label Image

51407-053-30ol.jpg (51407 053 30ol)

Label for Carvedilol Phosphate extended-release capsules, 80 mg strength. The label shows NDC 51407-053-30, a package size of 30 capsules, and highlights "Once a Day Dosing." Manufactured by Golden State Medical Supply, Inc. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.